Lisa A O'Donnell1, David A Axelson2, Robert A Kowatch2, Christopher D Schneck3, Catherine A Sugar4, David J Miklowitz4. 1. Semel Institute, University of California, Los Angeles, CA, USA. Electronic address: LOdonnell@mednet.umich.edu. 2. The Ohio State University College of Medicine, Columbus, OH, USA. 3. University of Colorado School of Medicine, Aurora, CO, USA. 4. Semel Institute, University of California, Los Angeles, CA, USA.
Abstract
BACKGROUND:Adolescents with bipolar disorder (BD) report lower quality of life (QoL) than adolescents with other psychiatric disorders. This study compared the efficacy of family-focused therapy for adolescents (FFT-A) pluspharmacotherapy to brief psychoeducation (enhanced care, or EC) plus pharmacotherapy on self-rated QoL in adolescents with BD over 2 years. METHODS:Participants were 141 adolescents (mean age: 15.6±1.4yr) with BD I or II who had a mood episode in the previous 3 months. Adolescents and parents were randomly assigned to (1) FFT-A, given in 21 sessions in 9 months of psychoeducation, communication enhancement training, and problem-solving skills training, or (2) EC, given in 3 family psychoeducation sessions. Study psychiatrists provided patient participants with protocol-based pharmacotherapy for the duration of the study. QoL was assessed with The KINDLRQuestionnaire (Ravens-Sieberer and Bullinger, 1998) during active treatment (baseline to 9 months) and during a post-treatment follow-up (9-24 months). RESULTS: The two treatment groups did not differ in overall QoL scores over 24 months. However, adolescents in FFT-A had greater improvements in quality of family relationships and physical well-being than participants in EC. For quality of friendships, the trajectory during active treatment favored EC, whereas the trajectory during post-treatment favored FFT-A. LIMITATIONS: We were unable to standardize medication use or adherence over time. Quality of life was based on self-report rather than on observable functioning. CONCLUSIONS: A short course of family psychoeducation and skills training may enhance relational functioning and health in adolescents with BD. The effects of different psychosocial interventions on peer relationships deserves further study.
RCT Entities:
BACKGROUND: Adolescents with bipolar disorder (BD) report lower quality of life (QoL) than adolescents with other psychiatric disorders. This study compared the efficacy of family-focused therapy for adolescents (FFT-A) plus pharmacotherapy to brief psychoeducation (enhanced care, or EC) plus pharmacotherapy on self-rated QoL in adolescents with BD over 2 years. METHODS:Participants were 141 adolescents (mean age: 15.6±1.4yr) with BD I or II who had a mood episode in the previous 3 months. Adolescents and parents were randomly assigned to (1) FFT-A, given in 21 sessions in 9 months of psychoeducation, communication enhancement training, and problem-solving skills training, or (2) EC, given in 3 family psychoeducation sessions. Study psychiatrists provided patientparticipants with protocol-based pharmacotherapy for the duration of the study. QoL was assessed with The KINDLRQuestionnaire (Ravens-Sieberer and Bullinger, 1998) during active treatment (baseline to 9 months) and during a post-treatment follow-up (9-24 months). RESULTS: The two treatment groups did not differ in overall QoL scores over 24 months. However, adolescents in FFT-A had greater improvements in quality of family relationships and physical well-being than participants in EC. For quality of friendships, the trajectory during active treatment favored EC, whereas the trajectory during post-treatment favored FFT-A. LIMITATIONS: We were unable to standardize medication use or adherence over time. Quality of life was based on self-report rather than on observable functioning. CONCLUSIONS: A short course of family psychoeducation and skills training may enhance relational functioning and health in adolescents with BD. The effects of different psychosocial interventions on peer relationships deserves further study.
Authors: Tina R Goldstein; Wonho Ha; David A Axelson; Benjamin I Goldstein; Fangzi Liao; Mary Kay Gill; Neal D Ryan; Shirley Yen; Jeffrey Hunt; Heather Hower; Martin Keller; Michael Strober; Boris Birmaher Journal: Arch Gen Psychiatry Date: 2012-11
Authors: Boris Birmaher; David Axelson; Benjamin Goldstein; Michael Strober; Mary Kay Gill; Jeffrey Hunt; Patricia Houck; Wonho Ha; Satish Iyengar; Eunice Kim; Shirley Yen; Heather Hower; Christianne Esposito-Smythers; Tina Goldstein; Neal Ryan; Martin Keller Journal: Am J Psychiatry Date: 2009-05-15 Impact factor: 18.112
Authors: David J Miklowitz; David A Axelson; Boris Birmaher; Elizabeth L George; Dawn O Taylor; Christopher D Schneck; Carol A Beresford; L Miriam Dickinson; W Edward Craighead; David A Brent Journal: Arch Gen Psychiatry Date: 2008-09
Authors: David J Miklowitz; Michael W Otto; Ellen Frank; Noreen A Reilly-Harrington; Jane N Kogan; Gary S Sachs; Michael E Thase; Joseph R Calabrese; Lauren B Marangell; Michael J Ostacher; Jayendra Patel; Marshall R Thomas; Mako Araga; Jodi M Gonzalez; Stephen R Wisniewski Journal: Am J Psychiatry Date: 2007-09 Impact factor: 18.112
Authors: Lisa A O'Donnell; Marc J Weintraub; Alissa J Ellis; David A Axelson; Robert A Kowatch; Christopher D Schneck; David J Miklowitz Journal: Fam Process Date: 2020-02-03
Authors: Thomas Jozefiak; Hanne K Greger; Hans M Koot; Christian A Klöckner; Jan L Wallander Journal: Qual Life Res Date: 2019-05-10 Impact factor: 4.147
Authors: Marc J Weintraub; Christopher D Schneck; Filippo Posta; John A Merranko; Manpreet K Singh; Kiki D Chang; David J Miklowitz Journal: J Consult Clin Psychol Date: 2022-01-27
Authors: David J Miklowitz; Jean M Addington; Mary P O'Brien; Danielle M Denenny; Marc J Weintraub; Jamie L Zinberg; Daniel H Mathalon; Barbara A Cornblatt; Michelle S Friedman-Yakoobian; William S Stone; Kristin S Cadenhead; Scott W Woods; Catherine A Sugar; Tyrone D Cannon; Carrie E Bearden Journal: Early Interv Psychiatry Date: 2021-08-23 Impact factor: 2.721
Authors: Caterina Del Mar Bonnín; María Reinares; Anabel Martínez-Arán; Esther Jiménez; Jose Sánchez-Moreno; Brisa Solé; Laura Montejo; Eduard Vieta Journal: Int J Neuropsychopharmacol Date: 2019-08-01 Impact factor: 5.176